ARS Pharmaceuticals files initial beneficial ownership statement for Chief Legal Officer John L. Slebir
SPRY•Chief Legal Officer John L. Slebir filed an initial beneficial ownership statement for ARS Pharmaceuticals on Nov. 4, 2026.
1. Ownership filing
ARS Pharmaceuticals Chief Legal Officer John L. Slebir filed an initial statement of beneficial ownership on Nov. 4, 2026.
